Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone

International Journal of Pharmaceutics

Volumn 388, Issue 1-2, 2010, Pages 181-189

  Bhardwaj, Upkar ^a   Burgess, Diane J ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Dexamethasone; Extruded and non extruded liposomes; Hydrophobic drug; In vitro release; Physicochemical properties; Sustained delivery

Indexed keywords

1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOCHOLINE; CHOLESTEROL; DEXAMETHASONE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; GLYCEROPHOSPHOLIPID; LIPOSOME; UNCLASSIFIED DRUG;

ARTICLE; CALORIMETRY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; ENTHALPY; HYDROPHOBICITY; IN VITRO STUDY; MEMBRANE; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TEMPERATURE; ZETA POTENTIAL;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DRUG CARRIERS; GLUCOCORTICOIDS; HYDROPHOBICITY; LIPOSOMES; PARTICLE SIZE; PHASE TRANSITION; PHOSPHATIDYLCHOLINES; TIME FACTORS;

EID: 76549092098     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.01.003     Document Type: Article

References (51)

1. Al-Muhammad J., Ozer A., and Hincal A. Studies on the formulation and in vitro release of ophthalmic liposomes containing dexamethasone sodium phosphate. J. Microencapsul. 13 (1996) 123-130
2. Al-Muhammed J., Ozer A., Ercan M., and Hincal A. In-vivo studies on dexamethasone sodium phosphate liposomes. J. Microencapsul. 13 (1996) 293-306
3. Benameur H., Latour N., Schandene L., Van Vooren J., Flamion B., and Legros F. Liposome-incorporated dexamethasone palmitate inhibits in-vitro lymphocyte response to mitogen. J. Pharm. Pharmacol. 47 (1995) 812-817
4. Biltonen R., and Lichtenberg D. The use of differential scanning calorimetry as a tool to characterize liposome preparations. Chem. Phys. Lipids 64 (1993) 129-142
5. Bonanomi M., Velvart M., and Weder H. Fate of different kinds of liposomes containing dexamethasone palmitate after intra-articular injection into rabbit joints. J. Microencapsul. 4 (1987) 189-200
6. Cevc G. Lipid properties as a basis for membrane modeling and rational liposomes design. In: Gregoriadis G. (Ed). Liposome Technology (1993), CEC Press, Boca Raton 1-36
7. Cevc G., and Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim. Biophys. Acta 1663 (2004) 61-73
8. Chidambaram N., and Burgess D. A novel in vitro release method for submicron sized dispersed systems. AAPS Pharm. Sci. 1 (1999) E11
9. Chono S., and Morimoto K. Uptake of dexamethasone incorporated into liposomes by macrophages and foam cells and its inhibitory effect on cellular cholesterol ester accumulation. J. Pharm. Pharmacol. 58 (2006) 1219-1225
10. Chono S., Tauchi Y., Deguchi Y., and Morimoto K. Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice. J. Drug Target. 13 (2005) 267-276
11. Chono S., Tauchi Y., and Morimoto K. Aortic drug delivery of dexamethasone palmitate incorporated into lipid microspheres and its antiatherosclerotic effect in atherogenic mice. J. Drug Target. 13 (2005) 407-414
12. Demetzos C. Differential scanning calorimetry (DSC): a tool to study the thermal behavior of lipid bilayers and liposomal stability. J. Liposome Res. 18 (2008) 159-173
13. DiMatteo M., and Reasor M. Modulation of silica-induced pulmonary toxicity by dexamethasone-containing liposomes. Toxicol. Appl. Pharmacol. 142 (1997) 411-421
14. Eroglu H., Kas H., Oner L., Turkoglu O., Akalan N., Sargon M., and Ozer N. The in-vitro and in-vivo characterization of PLGA:l-PLA microspheres containing dexamethasone sodium phosphate. J. Microencapsul. 18 (2001) 603-612
15. Farshi F., Ozer A., Ercan M., and Hincal A. In-vivo studies in the treatment of oral ulcers with liposomal dexamethasone sodium phosphate. J. Microencapsul. 13 (1996) 537-544
16. Gregoriadis G., and Davis C. Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. Biochem. Biophys. Res. Commun. 89 (1979) 1287-1293
17. Hickey T., Kreutzer D., Burgess D., and Moussy F. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials 23 (2002) 1649-1656
18. Hickey T., Kreutzer D., Burgess D., and Moussy F. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J. Biomed. Mater. Res. A 61 (2002) 180-187
19. Kaiser N., Kimpfler A., Massing U., Burger A., Fiebig H., Brandl M., and Schubert R. 5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties. Int. J. Pharm. 256 (2003) 123-131
20. Kallinteri P., Antimisiaris S., Karnabatidis D., Kalogeropoulou C., Tsota I., and Siablis D. Dexamethasone incorporating liposomes: an in vitro study of their applicability as a slow releasing delivery system of dexamethasone from covered metallic stents. Biomaterials 23 (2002) 4819-4826
21. Katragadda A., Singh M., and Betageri G. Encapsulation, stability, and in vitro release characteristics of liposomal formulations of stavudine (D4T). Drug Deliv. 6 (1999) 31-37
22. Kodama M., Miyata T., and Takaichi Y. Calorimetric investigations of phase transitions of sonicated vesicles of dimyristoylphosphatidylcholine. Biochim. Biophys. Acta: Lipids Lipid Metab. 1169 (1993) 90-97
23. Koning G., Schiffelers R., Wauben M., Kok R., Mastrobattista E., Molema G., ten Hagen T., and Storm G. Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum. 54 (2006) 1198-1208
24. Kruijff B.D., Cullis P., and Radda G. Differential scanning calorimetry and 31P NMR studies on sonicated and unsonicated phosphatidylcholine liposomes. Biochim. Biophys. Acta: Biomembranes 406 (1975) 6-20
25. Kulkarni S., and Vargha-Butler E. Study of liposomal drug delivery systems. 2. Encapsulation efficiencies of some steroids in MLV liposomes. Colloids Surf. B: Biointerfaces 4 (1995) 77-85
26. Lasch J., Weissig V., and Brandl M. Preparation of liposomes. In: Torchilin V., and Weissig V. (Eds). Liposomes: A Practical Approach (2003), Oxford University Press, New York 3-30
27. Liu D., Chen W., Tasi L., and Yang S. Microcalorimetric and shear studies on the effects of cholesterol on the physical stability of lipid vesicles. Colloids Surf. A: Physicochem. Eng. Asp. 172 (2000) 57-67
28. Lopes de Menezes D., and Vargha-Butler E. Study of liposomal drug delivery systems. 3. Dynamic in-vitro release of steroids from multilamellar liposomes. Colloids Surf. B: Biointerfaces 6 (1996) 269-277
29. Mayer L., Tai L., Bally M., Mitilenes G., Ginsberg R., and Cullis P. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim. Biophys. Acta 1025 (1990) 143-151
30. McElhaney R. The use of differential scanning calorimetry and differential thermal analysis in studies of model and biological membranes. Chem. Phys. Lipids 30 (1982) 229-259
31. Metselaar J., Wauben M., Boerman O., Van Lent P., and Storm G. Long-circulating liposomes for i.v. targeted delivery of glucocorticoids in arthritis. Cell Mol. Biol. Lett. 7 (2002) 291-292
32. Ozer A., and Talsma H. Preparation and stability of liposomes containing 5-fluorouracil. Int. J. Pharm. 55 (1989) 185-191
33. Papahadjopoulos D., Nir S., and Oki S. Permeability properties of phospholipid membranes: effect of cholesterol and temperature. Biochim. Biophys. Acta 266 (1972) 561-583
34. Parente R., and Lentz B. Phase behavior of large unilamellar vesicles composed of synthetic phospholipids. Biochemistry 23 (1984) 2353-2362
35. Patil S., and Burgess D. Liposome: design and manufacturing in injectable dispersed systems: formulation, processing, and performance. In: Burgess D. (Ed). Injectable Dispersed Systems: Formulation, Processing and Performance (2005), Taylor & Francis 249-304
36. Patil S., Rhodes D., and Burgess D. Biophysical characterization of anionic lipoplexes. Biochim. Biophys. Acta 1711 (2005) 1-11
37. Peschka R., Dennehy C., and Szoka F.J. A simple in vitro model to study the release kinetics of liposome encapsulated material. J. Control. Release 56 (1998) 41-45
38. Saarinen-Savolainen P., Jarvinen T., Taipale H., and Urtti A. Method for evaluating drug release from liposomes in sink conditions. Int. J. Pharm. 159 (1997) 27-33
39. Schimmer B., and Parker K. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic anlogues; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman J., Limbard L., and Gilman A. (Eds). Goodman & Gilman's Pharmacological Basis of Therapeutics (2001), McGraw-Hill
40. Sezer A., Akbuǧa J., and Baş A. In vitro evaluation of enrofloxacin-loaded MLV liposomes. Drug Deliv. 14 (2007) 47-53
41. Stanculescu I., Manea M., Chiosa V., and Mandravel C. A theoretical approach to the molecular interaction between cholesterol and 2-pyridine aldoxime methyl chloride (2-Pam). Analele UniversitǎŃii din Bucuresti-Chimie 1 (2006) 101-105
42. Suntres Z., and Shek P. Liposomes promote pulmonary glucocorticoid delivery. J. Drug Target. 6 (1998) 175-182
43. Szoka F.J., Milholland D., and Barza M. Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B. Antimicrob. Agents Chemother. 31 (1987) 421-429
44. Taniguchi K., Itakura K., Yamazawa N., Morisaki K., Hayashi S., and Yamada Y. Efficacy of a liposome preparation of anti-inflammatory steroid as an ocular drug-delivery system. J. Pharmacobiodyn. 11 (1988) 39-46
45. Taniguchi K., Yamazawa N., Itakura K., Morisaki K., and Hayashi S. Partition characteristics and retention of anti-inflammatory steroids in liposomal ophthalmic preparations. Chem. Pharm. Bull. (Tokyo) 35 (1987) 1214-1222
46. Taylor K., and Craig D. Physical methods of study: differential scanning calorimetry. In: Torchilin V., and Weissig V. (Eds). Liposomes: A Practical Approach (2003), Oxford University Press, New York 79-103
47. Tremblay G., Therien H., Rocheleau H., and Cormier Y. Liposomal dexamethasone effectiveness in the treatment of hypersensitivity pneumonitis in mice. Eur. J. Clin. Invest. 23 (1993) 656-661
48. Tsotas V., Mourtas S., and Antimisiaris S. Dexamethasone incorporating liposomes: effect of lipid composition on drug trapping efficiency and vesicle stability. Drug Deliv. 14 (2007) 441-445
49. van Dijck P., de Kruijff B., Aarts P., Verkleij A., and de Gier J. Phase transitions in phospholipid model membranes of different curvature. Biochim. Biophys. Acta 506 (1978) 183-191
50. van Dijck P., Kruijff B.D., Aarts P., Verkleij A., and Gier J.D. Phase transitions in phospholipid model membranes of different curvature. Biochim. Biophys. Acta: Biomembranes 506 (1978) 183-191
51. Vargha-Butler E., and Hurst E. Study of liposomal drug delivery systems. 1. Surface characterization of steroid loaded MLV liposomes. Colloids Surf. B: Biointerfaces 3 (1995) 287-295